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ABSTRACT 
Opioid receptor like 1 receptor (ORL1) is a family of G-protein coupled receptor, reported to produce cardio-protection against ischemia- 
reperfusion induced injury in rat heart. The present study has been designed to investigate the role of ORL1 receptor in ischemic 
preconditioning (IPC) induced protection in rat brain. IPC was induced by giving 3 episodes of ischemia and reperfusion. Global ischemia for 17 
min was given by occlusion of carotid artery followed by 24hr of reperfusion. Memory was assessed by measuring escape latency time (ELT) for 
consecutively 4 days and time spent in target quadrant (TSTQ) was measured on 5th day by using morrish water maze. IPC signif icantly 
decrease in infarct size and improvement in memory as compared to ischemia/reperfusion (I/R) in control group. Pretreatment with JTC-
801(1mg/kg, i.p.), a selective ORL1 receptor antagonist or Glibenclamide (1mg/kg, i.p.), the KATP channel blocker significantly reduce the 
amplitude of IPC induced cerebroprotection measured in terms of infarct size and positively affects the memory measured in terms of time 
spent in target quadrant (TSTQ) at 5th day as compare to IPC group. The cerebroprotective effect of IPC was significantly attenuated in JTC-801 
and Glibenclamide in combination as compare to Ischemic preconditioning (IPC) group and treated group (Glibenclamide). These results may 
indicate that cerebroprotective effect of IPC of brain and improvement of memory mediated through ORL1 receptor and activation of KATP 
channels.  
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INTRODUCTION 
Stroke is a cerebrovascular accident (CVA) characterized by 
rapidly lossed brain function due to disturbance in blood 
supply (Fagan et al., 2005) which is due to ischemia caused 
by thrombosis, embolism or hemorrhage (Sims et al., 2009)  
thus affected areas of brain are unable to function properly 
and ultimately died (Fagan et al., 2005) . Ischemic 
preconditioning (IPC) is a strong endogenous protective 
phenomenon of short alternative cycles of sub lethal 
ischemia followed by reperfusion before the subsequent 
prolonged ischemic insult which improves the tolerance 
against injury due to ischemia reperfusion (Fagan et al., 
2005; Murry et al., 1986; Tomai et al., 1999). Cerebral 
ischemic preconditioning is an endogenous neuroprotective 
phenomenon in which a noxious stimulus applied to brain 
confers transient protection against a subsequent ischemic 
insult which is injurious every time (Gidday et al., 2006). 
Orphan receptor having high degree of homology to the 
“classical” opioid receptors on structural origin has been 
termed as Opioid receptor like 1 (ORL1) (Mollereau et al., 
1994). The physiological function on which all emphasis has 
been taken is totally dependent on anatomical distribution of 
the ORL1 receptor (Mollereau et al., 2000). 
ORL1 receptor is widely distributed in the CNS particularly 
in the forebrain, in both the dorsal and ventral horns of 
spinal cord and throughout the brain stem (Salis et al., 2000). 
ORL1 receptor produce cardioprotection against ischemia 
reperfusion induced injury in rat heart (Suzuki et al., 2003; 
Lavania et al., 2013). It has been documented that ORL1 
receptor get upregulated during ischemic insult (Malinowska 
et al., 2002; Guo et al., 2008) and recently it has been 
reported in the laboratory that ischemic precondition 
produced protection of heart against ischemia-reperfusion 
induced injury by ORL1 receptor (Guo et al., 2008). This 
study was designed to elaborate and investigate the role of 
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opioid receptor like 1 (ORL1) receptor plays in ischemic 
preconditioning induced protection in the brain of rat. 
MATERIALS AND METHODS 
Experimental Animals 
In the behavioral study for Ischemic preconditioning of 
brain, age matched albino wistar rats, weighing about 220-
250g have been employed in present research. Animals were 
kept in polypropylene cages with husk bedding and were 
feed on standard chow diet with water ad libitium and a 
semi-sound proof laboratory was selected to carry out all 
behavioral assessments in between 9.00 AM to 06.00 PM. 
The experimental protocol was approved by the Institutional 
Animal Ethical Committee (IAEC) in accordance with the 
national guidelines on the use of laboratory animals 
(GLAIPR/CPCSEA/IAEC/2014/P.C01/R01).  All the animals 
selected for this experiment were taken from age-matched 
group of rats to avoid the variability among these 
experimental groups and procured from animal house of 
Institute of Pharmaceutical research, GLA University, Matura, 
Uttar Pradesh, India (1260/P0/ac/09/CPCSEA). 
Drugs and Chemicals 
JTC-801 (Sigma-Aldrich, Bangalore, India) and Glibenclamide 
(Medrose drug and pharmaceuticals Pvt. Ltd, India) were 
dissolved individually in DMSO solution before use. 1% 
solution of TTC stain (CDH Pvt. Ltd, New Delhi) was prepared 
in Tris-chloride buffer (CDH Pvt. Ltd., New Delhi), pH was 
adjusted to 7.4 pH and was used to measure cerebral infarct 
size. All other reagents used in present investigation were 
taken of analytical grade and freshly prepared (CDH 
Chemicals, Delhi). 
Ischemic Brain Preconditioning 
Rats were anesthetized using thiopental sodium (30 mg/kg, 
i.p.) (Kushwaha et al., 2011). Left and right common carotid 
arteries were exposed by a midline ventral incision in the 
neck which will isolated from the vagus nerve and 
surrounding tissue. A shoelace knot was tied with cotton 
thread by passing it below the each of carotid arteries and 
after 17 min of global cerebral ischemia, reperfusion was 
allowed for 24 h and incisions were sutured in layers 
(Himori et al., 1990; Rehni et al., 2008). The sutured area was 
cleaned with 70% ethyl alcohol and then sprayed with 
antiseptic dusting powder. The animals were shifted 
separately to their home cage and were allowed to recover 
overnight; finally behavioral assessment of the animals was 
done instantaneously before surgical procedure as well as 24 
h after the surgery. The animals were kept on heating pad 
during surgery in order to uphold the body temperature to 
avoid the effect of temperature variations on the results 
obtained after completion of study. The carotid arteries were 
occluded for 1 min followed by reperfusion for 1 min, for 
previous episodes of ischemic preconditioning and three 
such cycles of ischemia and reperfusion were perform before 
bilateral carotid artery occlusion (Rehni et al., 2008., 2011). 
A single dose of JTC-801, a ORL1 antagonist drug (1mg/kg; 
i.p.) (Rawls et al., 2007) was given 30 min and/or 
Glibenclamide (1mg/kg i.p.) (Dubey et al., 2012) was given 
60 min before the ischemic preconditioning. For assessment 
of memory, Morris water maze (MWM) test was performed 
(Rehni et al., 2008). 
 
Experimental Protocol 
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GROUP I–(Sham group n=8): Rats were subjected to 
surgical procedure isolate the carotid arteries and a cotton 
thread was passed below it in such a way that arteries were 
not occluded in any extant. After 17 min, threads were 
removed and animal was sutured back then allowed to 
recover for a time period of 24 h. 
GROUP II-(Ischemia Reperfusion (I/R) group; n=8): Each 
rat was subjected to 17 min of global cerebral ischemia 
followed by reperfusion for 24 h. 
GROUP III-(Ischemic preconditioning group; n=8): Three 
episodes comprising 1 min occlusion and 1 min reperfusion 
shall be followed by 17 min global ischemia then 24hr of 
reperfusion. 
GROUP IV-(Vehicle Treated Group; n=8): Rats were 
administered vehicle i.e. dimethyl sulfoxide (DMSO) 30 
minutes before ischemic preconditioning and rest of 
procedure was same as described in group III. 
GROUP V-(JTC-801 (1mg/kg; i.p.): Treated Ischemic 
preconditioning group; n=8): JTC-801 (1mg/ kg; i.p) 
(Rawls et al., 2007) was administered 30 min before 
preconditioning and rest of procedure was same as 
described in group III. 
GROUP VI-(Glibenclamide 1mg/kg; i.p.): Treated 
Ischemic preconditioning group; n=8): Glibenclamide 
(1mg/kg;i.p.) (Dubey et al., 2012) was administered 60 
minutes before the preconditioning and rest procedure was 
same as described in group III. 
GROUP VII–(JTC-801 and Glinenclamide treated 
Ischemic preconditioning group; n=8): 
Rats were administered Glibenclamide (1mg/kg; i.p.) (Dubey 
et al., 2012) 60 minutes before and JTC-801(1 mg/kg i.p.) 
(Rawls et al., 2007)30 minutes before the preconditioning 
and rest procedure was followed same as described in group 
III. 
Assessment of infract size  
At the end or 24 hr of reperfusion after global cerebral 
ischemia, animals were sacrificed by spinal dislocation brain 
was removed and placed immediately in ice cold saline for 
10 min. Brain samples were sliced into identical coronal 
section of about 1mm thickness and incubated in 1% of 0.2 M 
Tris buffer of pH 7.4 at 370C for 20 min  (Rehni et al., 2008; 
Bochelen et al., 1999) then  red formazone pigment obtained 
from conversion of triphenyltetrazolium chloride (TTC) by 
NAD and dehydrogenase enzyme was used to stain the viable 
cells to deep red. The infracted cells remain unstained dull 
yellow because they lose the enzyme and co-factor. A visible 
plastic grid with 100 squares of 1cm2 area was placed over 
the brain slices which were kept in a glass plate. The number 
of squares on either side of plastic grid was counted for 
calculating the average area of each brain slice. Similarly the 
yellow area was also calculated by transparent plastic grid 
method and whole brain slices were weighed and Infracted 
area was expressed as a percentage of total brain volume. 
Percentage of total wet weight of brain was expresses as the 
infracted dull yellow portion (Rehni et al., 2011). 
Statistical Analysis 
All values were expressed as mean ± standard deviation 
(S.D). Standard analysis was done by using graph pad prism 
software. The data obtained from the various groups were 
statistically analyzed by using one-way analysis of variance 
(ANOVA) and *P < 0.05 was considered as statistically 
significant. 
Assessment of memory and learning using the Morris 
water maze (MWM) 
The Morris Water Maze, a circular pool having water used to 
train the rats or mice by using extra-maze visual clues to 
locate an escape platform hidden beneath the surface of 
opaque water (Morris., 1984).The visible platform version of 
Morris Water Maze method is used to estimates the non-
hippocampal tasks, disrupted by dorsal striatum lesions of 
brain but hidden platform method is used for spatial 
memory which is very sensitive to hippocampal damage 
(McDonald et al., 1994). 
It also concerned that water maze may be used to induce 
anxiety or fear in mice, suggesting involvement of amygdale 
as well as hippocampus (Akirav et al., 2001).  Learning and 
memory in animals is assessed by Morrish water maze test 
which is a swimming based model where animals learn to 
escape on a hidden platform. Morrish water maze contains a 
large circular tank of 45 cm height with 150 cm in diameter 
and filled with opaque water to a depth of 30 cm, maintained 
at temperature of 28±1°C. Water was made opaque with 
white colored non-toxic dye. Tank was divided into four 
chambers which were equal in size with the help of two 
threads fixed at right angles to each other on a rim of tank. A 
white platform of 10 cm2 area was submerged in tank and 
placed inside the target quadrants below 1 cm surface of 
water. The position of platform must not be changed during 
whole training sessions and estimation experiments. 
Each animal was subjected to four successive training trials 
on each day with inter trial gaps of 5 min. The animal was 
gently placed in opaque water between quadrants, facing the 
wall of tank at every trial drop location keep changing then 
animal was allowed 120 sec of time to locate underwater 
platform. When the platform was found by animal, it was 
allowed to stay on the platform for 20 sec and if failed to find 
the platform within 120 sec, it was guided gently onto the 
platform and allowed to stay there for 20 sec. The escape 
latency time (ELT) to locate the hidden platform in water 
maze was noted on 4th day as index of learning and memory. 
Each animal was subjected to four training trials on each day 
for four consecutive days. Starting position of animal was 
changed with each exposure as mentioned below. The target 
quadrants (Q4) remain constant during entire training 
periods like Day1-Q1 Q2 Q3 Q4, Day2-Q2 Q3 Q4 Q1, Day3-Q3 
Q4 Q1 Q2 and Day4-Q4 Q1 Q2 Q3. 
On fifth day of study the platform was removed.  The study 
was repeated for each mouse by allowing exploring the tank 
for 120 sec and recording the mean time spent in all 
quadrants. The mean time spent by animal in the target 
quadrant searching hidden platform was noted as an index of 
memory. The experimenter will always stand at the same 
position. The special care was taken about visual clues in the 
laboratory which can helps to find the relative location in 
water maze during the total duration of study. All of trials 
were completed between 09:00 AM to 06:00 PM (Morris., 
1984; Sharma et al., 2008). 
RESULTS 
Effect of treatment/procedure on ischemia and 
reperfusion induced cerebral infarct size 
1. Effect of ischemia and reperfusion on infarct size of 
rat brain. 
Global ischemia of 17 minutes followed by reperfusion of 24 
hr significantly increased the brain infarct size as compared 
to sham control group (Slide 2, Figure 1, and Table 1). 
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2. Effect of ischemic preconditioning on injury in rat 
brain. 
Three episodes of IPC each episode consist of 1 min of 
ischemia and 1 min of reperfusion significantly reduced I/R 
induced increase in infarct size of rat brain (Slide 3, Figure 1, 
Table 1). 
3. Effect of IPC induced protective effect on brain in 
vehicle pretreated rat. 
Administration of vehicle 30 min prior to the IPC each 
episode consist of 1 min of ischemia and 1 min of reperfusion 
could not affect protective effect of IPC in terms of infarct 
size (Slide4, Figure 1, Table 1). 
4. Effect of IPC induced protective effect on brain in 
JTC-801(1mg/kg, i.p.) pretreated rat. 
Administration of JTC-801 (1mg/kg, i.p.) 30 minutes before 
the three episodes of IPC each episode consist of 1min of 
ischemia and 1 min of reperfusion significantly abolished the 
restoration of IPC induced protection noted in terms of 
increase in infarct size (Slide 5, Figure 1, Table 1). 
5. Effect of IPC induced protective effect on brain in 
Glibenclamide (1mg/kg, i.p.) 
Administration of Glibenclamide (1mg/kg i.p.) 60 minutes 
before the three episodes of IPC each episode consist of 1 
min of ischemia and 1 min of reperfusion significantly 
abolished the restoration of IPC induced protection noted in 
terms of increase in infarct size (Slide 6, Figure 1, Table 1). 
6. Effect of IPC induced protection in JTC-
801(1mg/kg; i.p.)and Glibenclamide (1mg/kg, i.p.) 
pretreated rat brain. 
Administration of JTC-801 (1mg/ kg, i.p.) 30 minutes before 
and Glibenclamide (1mg/kg i. p.) 60 minutes before the three 
episodes of IPC each episode consist of 1 min of ischemia and 
1 min of reperfusion were produce additional effect on 
neuronal injury noted in terms of infarct size (Slide 7, Figure 
1, Table 1). 
 
 
            
Slide 1: Sham group                    Slide 2: I/R group           Slide 3: IPC Group 
 
Slide 4: Vehicle treated  IPC group              Slide 5: JTC treated group 
    
Slide 6: Glibenclamide treated IP group Slide 7: Glibenclamide plus JTC-801 treated IPC group 
Figure 1: Effect of treatment/procedure on ischemia and reperfusion induced cerebral infarct size 
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Effect of ischemic preconditioning and/or treatment on 
impairment of memory  
Global ischemia of 17 minutes followed by reperfusion of 24 
hr significantly cause impairment of memory in terms of 
reduced time spend in target quadrant (Q4) in search of 
missing platform as compared to sham control group. Three 
episodes of IPC significantly reduced I/R induced decrease 
the memory in terms of time spend in target quadrant (Q4) 
in search of missing platform (Figure 3, Table 1). 
Administration of vehicle 30 min prior to three episodes of 
IPC could not affect protective effect of IPC on memory in 
terms of time spend in target quadrant (Q4) in search of 
missing platform. Administration of JTC-801 (1mg/kg, i.p.) 
30 minutes before the conduction of three episodes of IPC 
significantly abolished the restoration of IPC induced 
protective effect of memory noted in terms of time spend in 
target quadrant (Q4) in search of missing platform. 
Administration of Glibenclamide (1mg/kg, i.p.) 60 minutes 
before conduction of three episodes of IPC significantly 
abolished the restoration of IPC induced protective effect on 
memory noted in terms of time spend in target quadrant in 
search of missing platform (Q 4). Pretreatment of JTC-801 
and Glibenclamide showed a significant (P<0.05) loss in 
memory as by decreasing the time spend in target quadrant 
(Q4) compare to the sham control group (Figure 3, Table 1). 
Administration of JTC-801 (1mg/kg, i.p.) 30 minutes before 
and Glibenclamide (1mg/kg i.p.) 60 minutes before the 
conduction of three episodes of IPC were unable to produce 
any additional  effect on memory noted in terms of time 
spend in target quadrant (Q 4) in search of missing platform 
during retrieval trial (Figure 2, 3, Table 1). 
 
Table 1: Involvement of Opioid like receptor1 (ORL1) receptor in ischemic preconditioning induced protection in rat brain. 
Group %  
Infarct Size  
Escape Latency Time (In %) Time Spend In Target 
Quadrant (TSTQ in %) 
Day 1 Day 4 
Sham control  8.75% 65.68 26.95 56.20 
Ischemia reperfusion (I/R)  66.07% 67.85 28.02 24.29 
Ischemic preconditioning (IPC) 27.49% 59.85 28.45 50.32 
IPC+ vehicle treated  34.00% 70.30                32.60 43.62 
IPC+ JTC-801 52.06% 58.16              29.70 27.95 
IPC+ Glibenclamide 46.51% 67.32              30.40 30.60 
IPC+JTC-801+Glibenclamide 58.57% 63.80               25.21 25.66 
 
 
Figure 2: Effect of ischemic preconditioning and interventions on ischemia reperfusion-induced cerebral infarct size. Values are 
the mean ± SD. a=p< 0.05 vs. Sham control. b =p< 0.05 vs. I/R control. c=p<0.05 vs. IPC. d = p< 0.05 vs. IPC+Glibenclamide 
treated. 
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Fig 3: Morris water maze escape latency time of day 1and day 4. IPC-Ischemic preconditioning, I/R-Ischemia reperfusion, Glb-
Glebenclamide, Values are expressed as mean ± SD. a =P< 0.05 vs. day1 ELT in sham; b =p< 0.05 vs. day 1 ELT in I/R;  c =p< 0.05 
vs. day 1 ELT in IPC; d =P< 0.05 vs. day 1 ELT in IPC+Vehicle treated; e=p<0.05 vs. day ELT in IPC+JTC-801 treated; f =P<0.05 vs. 
day 1 ELT in IPC+Glbtreated; g=p<0.05 vs. day 1 ELT in IPC+JTC-801+Glb treated. 
 
 
Figure 4: Effect of ischemic preconditioning and interventions on ischemia reperfusion-induced decrease in time spent in 
target quadrant (TSTQ) as assessed using the Morris water maze. IPC- Ischemic preconditioning; I/R-Ischemia reperfusion; Glb-
Glibenclamide. Values are the mean ± SD. a=p< 0.05 vs. time spent in other quadrant i.e. Q1, Q2, Q3 in sham group; b =p< 0.05 vs. 
time spent in target quadrant i.e. Q-4 in sham group; c =p< 0.05 vs. time spent in target quadrant in I/R group; d =p< 0.05 vs. 
time spent in target quadrant in the ischemic preconditioning (IPC) group. 
 
DISCUSSION 
Memory is ability to program, store, retain and recollect 
information with past experiences in the brain. It can be 
thought of general terms as the use of past experience to 
affect or influence present behavior.  In present study, wistar 
albino rats have been used because they are easily available 
and lower in cost and the global cerebral I/R model 
employed to report to simulate the clinical situation of 
cerebral ischemia (Rehni et al., 2008; Jenkins et al., 1981). 
Global cerebral ischemia is given by 17 min of occlusion 
followed by reperfusion for 24h. In this study, global cerebral 
ischemia reperfusion produced a significant rise in infarct 
size and induced impairment of learning and memory (Rehni 
et al., 2008; Rehni et al., 2011; Bochelen et al., 1999). In 
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previous studies it was reported that ischemic 
preconditioning prevent the ischemia and reperfusion 
induced cerebral infarct size and impairment of memory 
(Rehni et al., 2008; Rehni et al., 2011).Therefore in the 
present investigation we employed Morris water maze test 
for memory. Significant increment in infarct size and 
impairment of learning and memory was produced by global 
cerebral ischemia reperfusion and findings are in line with 
earlier reports (Rehni et al., 2008; Bochelen et al., 1999). 
Moreover ischemic preconditioning was observed to prevent 
ischemia and reperfusion induced cerebral infarct size and 
impairment of memory which is in concordance with earlier 
conclusions (Rehni et al., 2008; Rehni et al., 2011; Bochelen 
et al., 1999; Dunham et al., 1957) 
Administration of JTC-801 selective ORL1 receptor 
antagonist markedly reduced time spent in target quadrant 
(Q4) in search of missing platform during retrieval trial 
which reflecting impairment of learning and memory and 
attenuated the IPC induced decrease in infarct size. 
Therefore based on the present experimental data, it may be 
suggested that the beneficial effects of ischemic-
preconditioning in global cerebral ischemia-reperfusion 
induced neuronal injury may be mediated through ORL1 
receptor. However the absence of analytical estimation of 
ORL1 receptor in preconditioned brain as well as in ORL1 
inhibited brain is a limitation in the present study and such 
investigations using histochemical studies may ascertain 
them intracellular details about the potential role of ORL1 
receptor in ischemic preconditioning of brain. Moreover, a 
detailed study of complete pathway following ORL1 receptor 
activation that leads to the ischemic preconditioning still 
requires an exhaustive experimental evaluation. 
Nevertheless, further studies are needed to confirm the 
biochemical system that might be involved into the 
protection served by ischemic preconditioning of brain. 
KATP channels have been reported to produce 
neuroprotection (Sun et al., 2010) and Glibenclamide is 
reported to block KATP channels (Dubey et al., 1999). 
In the present study Glibenclamide has attenuated Ischemic 
preconditioning (IPC) induced cerebral injury, but 
glibenclamide cause less damage as compare to co 
administration of both drugs noted in terms of infarct size. 
Co administration of JTC-801 and Glibenclamide produced 
detriment additive effect on IPC induced neuroprotection as 
compare to individual administration of both drugs. 
Nociceptin on binding to ORL1 receptor shows arteriodilator 
response by activation of cAMP/cGMP and subsequent 
opening of KATP (Armstead et al., 1999) which shows 
neuroprotection in ischemic injury (Suzuki et al., 200). 
Therefore it may be probable to suggest that neuroprotective 
effect of IPC may be mediated through up regulation of ORL1 
receptor and subsequently opening of KATP channels. 
SUMMERY AND CONCLUSION 
The present study was designed to investigate the possible 
involvement of ORL1 receptor in ischemic brain 
preconditioning in rat brain. Three episodes each comprising 
1 min of ischemia by occlusion of carotid artery and 1 min of 
reperfusion were employed in the present study to produce 
ischemic brain preconditioning. Infract size was measured to 
access the effect of ischemic brain preconditioning on 
ischemia reperfusion induced cerebral injury. Many salient 
features may be summarized on the basis of results obtained 
from this study like, firstly three episode of ischemic 
preconditioning was observed to prevent ischemia and 
reperfusion induced cerebral infarct size and impairment of 
memory measured in terms of infract size and time spent in 
target quadrant (Q4), secondly protective effect of ischemic 
brain preconditioning was attenuated by JTC-801 (1mg/kg, 
i.p.), an ORL1 receptor antagonist which suggest the 
involvement of ORL1 receptor induced cerebral protection. 
Third one is Glibenclamide (1mg/kg, i.p.), KATP channel 
blocker treatment significantly attenuate the 
cerebroprotective effect of ischemic brain preconditioning, is 
suggests that cerebroprotective effect of ischemic brain 
preconditioning is mediated through KATP channels and 
finally combination of JTC-801 and Glibenclamide produce 
detrimental additive effect on IPC induced cerebral 
protection as compared to individual drug. Therefore it may 
be suggested that the cerbroprotective effect of ischemic 
brain preconditioning may be mediated through ORL1 
receptor and opening of KATP channels. 
It may also be concluded that ischemic brain preconditioning 
induced cerebral protection may be mediated in part by 
ORL1 receptor and opening of KATP channels. 
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